Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 176-200 of 492 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
06 Dec 2023
Reporting date
05 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
29 Nov 2023
Reporting date
29 Nov 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
14 Nov 2023
Reporting date
14 Nov 2023
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
EFFECT File 333-275410

EFFECT filing

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-275410

PROSPECTUS

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-275410

REGISTRATION STATEMENT

Filing date
08 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
02 Nov 2023
Reporting date
02 Nov 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
30 Oct 2023
Reporting date
24 Oct 2023
Next action
Verify source filing
DEFA14A File 001-39685

ADDITIONAL MATERIALS

Filing date
27 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39685

PROXY STATEMENT

Filing date
27 Oct 2023
Reporting date
19 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
24 Oct 2023
Reporting date
24 Oct 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
29 Sep 2023
Reporting date
29 Sep 2023
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
29 Sep 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
NT 10-K File 001-39685

NOTIFICATION OF LATE FILING

Filing date
29 Sep 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
25 Sep 2023
Reporting date
25 Sep 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
25 Sep 2023
Reporting date
22 Sep 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
08 Sep 2023
Reporting date
07 Sep 2023
Next action
Verify source filing
4

4 filing

Filing date
31 Aug 2023
Reporting date
31 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
24 Jul 2023
Reporting date
21 Jul 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
20 Jul 2023
Reporting date
20 Jul 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
22 Jun 2023
Reporting date
22 Jun 2023
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
01 Jun 2023
Reporting date
01 Jun 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .